These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39246674)

  • 1. A Prognostic Risk Signature of Two Autophagy-Related Genes for Predicting Triple-Negative Breast Cancer Outcomes.
    Yu B; Xing Z; Tian X; Feng R
    Breast Cancer (Dove Med Press); 2024; 16():529-544. PubMed ID: 39246674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.
    Yan C; Liu Q; Jia R
    Front Oncol; 2022; 12():829045. PubMed ID: 35186763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and Therapeutic Values of Autophagy-related Genes in Triple-negative Breast Cancer.
    Liu M; Li L; Huang S; Pan X; Dai H; Chen ZS; Pan Y; Fang S
    Recent Pat Anticancer Drug Discov; 2022; 17(4):380-386. PubMed ID: 34847851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy-related prognostic signature for survival prediction of triple negative breast cancer.
    Yang Q; Sun K; Xia W; Li Y; Zhong M; Lei K
    PeerJ; 2022; 10():e12878. PubMed ID: 35186475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration.
    Ying B; Xu W; Nie Y; Li Y
    Dis Markers; 2022; 2022():8446857. PubMed ID: 36452344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer.
    Lv X; He M; Zhao Y; Zhang L; Zhu W; Jiang L; Yan Y; Fan Y; Zhao H; Zhou S; Ma H; Sun Y; Li X; Xu H; Wei M
    Cancer Cell Int; 2019; 19():172. PubMed ID: 31297036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.
    Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM
    Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram based on autophagy related genes for predicting the survival in melanoma.
    Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
    BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an ubiquitin-proteasome system signature for predicting prognosis and providing therapeutic guidance for patients with triple-negative breast cancer.
    Chen X; Ren C; Zhou Z; Chen J; Fan X; Li X; Chen J; Zhu J
    J Gene Med; 2024 Jan; 26(1):e3584. PubMed ID: 37605934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.
    Hou C; Cai H; Zhu Y; Huang S; Song F; Hou J
    Front Oncol; 2020; 10():558596. PubMed ID: 33178587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
    Li X; Chen J; Yu Q; Huang H; Liu Z; Wang C; He Y; Zhang X; Li W; Li C; Zhao J; Long W
    Front Genet; 2021; 12():569318. PubMed ID: 33796128
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer.
    Hu Y; Zou D
    PLoS One; 2021; 16(12):e0260811. PubMed ID: 34965257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.
    Wang N; Gu Y; Chi J; Liu X; Xiong Y; Zhong C; Wang F; Wang X; Li L
    Front Genet; 2021; 12():721873. PubMed ID: 34408776
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer.
    Liu J; Ling Y; Su N; Li Y; Tian S; Hou B; Luo S; Zhao L; Shi M
    Transl Cancer Res; 2022 Jan; 11(1):181-192. PubMed ID: 35261895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the ferroptosis-related
    Yuan L; Liu J; Bao L; Qu H; Xiang J; Sun P
    Front Oncol; 2023; 13():1032364. PubMed ID: 37064114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast Cancer.
    Qiu Y; Chen Y; Shen H; Yan S; Li J; Wu W
    J Inflamm Res; 2024; 17():5253-5269. PubMed ID: 39135978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
    Cui J; Jiang H
    Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analyses of genes associated with oxidative stress and cellular senescence in triple-negative breast cancer.
    Wu L; Zheng H; Guo X; Li N; Qin L; Li X; Lou G
    Heliyon; 2024 Jul; 10(14):e34524. PubMed ID: 39130410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.